Oncimmune replaces outgoing CFO
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Oncimmune Holdings PLC director and CFO Andrew Millet has stepped down but will remain with the company for six months to ensure an orderly transition.
The company appointed Matthew Hall to replace Millet. Hall recently served as CFO at Tusk Therapeutics and Simbec-Orion Group.
Oncimmune is an early-cancer detection company.
